[Revealed] Trump's Next AI Executive Orders?
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Shares Stats
| Shares Outstanding | 2,503,140,000 |
| Shares Float | 2,495,380,000 |
| Shares Short | 27,710,000 |
| Insider Holdings | 7% |
| Institution Holdings | 80.62% |
About Merck & Co Inc
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
General
| Name | Merck & Co Inc |
| Ticker | MRK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 73,000 |
Highlights
| Analyst Target | 101.95 |
| Market Cap | 223,601,500,000 |
| PE Ratio | 13.80 |
| PEG Ratio | 0.81 |
| EBITDA | 28,330,000,384 |
Financials
| Curr Year EPS Estimate | 8.93 |
| Next Quarter EPS Estimate | 2.42 |
| Profit Margin | 25.87% |
| Operating Margin | 35.05 |
| Return on Assets | 0.13 |
| Return on Equity | 0.35 |
| Revenue | 63.4B |
| Earnings Per Share | 6.49 |
| Revenue Per Share | 25.21 |
| Gross Profit | 49,245,999,104 |
| Quarterly Revenue Growth | -0.02 |
Valuation
| Trailing PE | 13.79 |
| Forward PE | 9.20 |
| Price/Sales (Trailing 12 Mt.) | 3.51 |
| Price/Book (Most Recent Quarter) | 4.60 |
Dividend
Merck & Co Inc pays out a dividend of $3.22 per share, with a dividend yield of 3.60%.
MRK's next dividend payment will be made to shareholders on October 7, 2025.
They pay out 46.32% of their earnings out as a dividend.
Recent Dividends
| Oct 7, 2025 | $0.81 |
| Jul 8, 2025 | $0.81 |
| Apr 7, 2025 | $0.81 |
| Jan 8, 2025 | $0.81 |
| Oct 7, 2024 | $0.77 |
| Jul 8, 2024 | $0.77 |
| Apr 5, 2024 | $0.77 |
| Jan 8, 2024 | $0.77 |
Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline
According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.
Microsoft resolves European Union probe into Teams
LONDON (AP) — European Union regulators have accepted Microsoft's to Teams, resolving a long-running antitrust investigation that targeted the company's messaging and videoconferencing app.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Nvidia to invest $5 billion in Intel; companies will work together on AI infrastructure and PCs
NEW YORK (AP) — Nvidia, the world's leading chipmaker, announced on Thursday that it's investing $5 billion in Intel and it will collaborate with the struggling semiconductor company on products.
George Soros' philanthropy reaches for new ideas as it grapples with the limits of its power
NEW YORK (AP) — Open Society Foundations, the family philanthropy of hedge fund billionaire , has consistently been one of the largest funders of around the world. But what that means has changed in recent years, with a new focus on addressing inequality.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Europe urgently needs to solve its Russian drone problem, Baltic officials say
VINSKI, Estonia (AP) — Estonia is extending a fence along its border with Russia and building anti-tank ditches and bunkers in preparation for a potential conflict with Moscow. But those defenses won’t guard against the threat it and its NATO allies face from Russian drones and .
Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs
President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Ethereum Faces Alt-Season Pressure: Why Fusaka Upgrade Could Be A Gamechanger
Ethereum is once again under the spotlight as traders declare the arrival of a fresh alt-season. With capital rotating into high-beta tokens like Solana, Avalanche, and meme coins, Ethereum (Crypto: ETH) finds itself squeezed between being the "blue-chip" altcoin and the slowest horse in a fast-moving race.
Supreme Court will weigh expanding Trump’s power to shape agencies by overturning 90-year-old ruling
WASHINGTON (AP) — said Monday it will consider expanding President Donald Trump's power to shape independent agencies by overturning a nearly century-old decision limiting when presidents can fire board members.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Northrop Grumman cargo ship reaches the International Space Station a day late after engine issue
CAPE CANAVERAL, Fla. (AP) — A supply ship arrived at the International Space Station on Thursday after a day’s delay due to a .
Republican leaders reject Democratic health care demands for bill to avoid shutdown
WASHINGTON (AP) — Republican leaders in the House and Senate said Wednesday that they will reject for an immediate , challenging Democrats to vote against a stopgap spending bill that doesn't include them but will keep the government open at the end of the month.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
UNHCR official warns that the 1951 refugee convention is increasingly under threat
The U.N. refugee agency said Wednesday that governments around the world, especially in the Global North, and , are increasingly undermining the global convention on refugees and asylum-seekers — even threatening its very existence.
Opendoor Is A 'Total Clown Show' Legendary Investor Says
Legendary hedge fund manager George Noble called Opendoor Technologies Inc.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Trump's Cryptic 'Intel At $30' Post Sparks Debate As INTC Shares Slip Over 2% In Friday's Pre-Market
President Donald Trump has created a buzz with a cryptic post on his social media platform, Truth Social, this time, the focus is on Intel Corporation (NASDAQ: INTC).
3 members of federal control board in Puerto Rico sue Trump and others for illegal firings
SAN JUAN, Puerto Rico (AP) — Three members of a federal control board overseeing Puerto Rico’s finances, by the administration of U.S. President Donald Trump, filed a lawsuit in federal court on Thursday alleging their firings were illegal.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
British department store Harrods warns customers that some personal details taken in data breach
LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.
Edmunds small SUV comparison: 2026 Chevrolet Equinox vs. 2026 Hyundai Tucson
The and are two popular choices for shoppers looking at small SUVs. They’re also notable for their recent updates. The Equinox’s 2025 redesign ushers in more squared-off styling, technology and safety-related upgrades, and a new rugged-looking Activ trim level. The Tucson’s updates are milder but include refreshed styling and new tech features.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Federal judge tosses Trump's $15B defamation lawsuit against New York Times
TAMPA, Fla. (AP) — A federal judge in Florida on Friday tossed President Donald Trump’s against New York Times.
'Greedy People Would Never Ask That Question,' Ramsey Says, Reassuring Oil Worker That Ambition For Family Isn't Greed
Dave Ramsey reassures young father that earning more money does not make him greedy. Greed comes from the heart, not a paycheck.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Here's How Much You Would Have Made Owning Applied Industrial Techs Stock In The Last 5 Years
Applied Industrial Techs (NYSE: AIT) has outperformed the market over the past 5 years by 21.84% on an annualized basis producing an average annual return of 36.48%. Currently, Applied Industrial Techs has a market capitalization of $9.78 billion.
Will mortgage rates drop further after the Fed's rate cut? Not necessarily
LOS ANGELES (AP) — Hoping that mortgage rates will keep dropping following since last year? Don't bank on it.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Farm Aid celebrates 40 years of supporting family farmers with a concert in Minneapolis
MINNEAPOLIS (AP) — Farm Aid — the annual fundraising concerts launched by and during the farm crisis of the 1980s — celebrates its 40th anniversary on Saturday in Minneapolis.
Billionaire says $2.3 billion Banamex stake signals confidence in Mexico's economy
MEXICO CITY (AP) — A day after Citigroup announced it would sell a 25% stake in Banamex to billionaire Fernando Chico Pardo, the Mexican businessman said his $2.3 billion investment should be read as a sign of confidence in Mexico’s government and economic potential.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
What Is Going On With Nvidia Stock On Monday?
Nvidia expands partnership with OpenAI to deploy 10 gigawatts of systems for AI infrastructure, with $100 billion investment and rapid growth.
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Fallout from cyberattack on check-in systems at 3 European airports continues for 2nd day
BRUSSELS (AP) — Fallout from a cyberattack that affected check-in systems at several European airports extended into a second full day on Sunday, as passengers faced dozens of cancelled and delayed flights and airport teams scrambled to limit the damage to travel plans.
Here's Novo Nordisk's First Oral Obesity Drug In Europe With Proven Heart Health Impact
EMA approved Rybelsus' label update after the SOUL trial showed it cuts heart attack, stroke, and death by 14% in high-risk type 2 diabetes patients.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico
U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.